Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1
The experimentally established mechanism targets of Tetrabuthylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL26605872 | 0.98 | SLC22A1 (0.52) | SLC22A1TP53GPR84FFAR1SLC22A2 | |
| Tetrabuthylammonium SCHEMBL28396905 | 0.98 | SLC22A1 (0.52) | SLC22A1TP53GPR84FFAR1SLC22A2 | |
| Tetrabuthylammonium SCHEMBL27706863 | 0.98 | SLC22A1 (0.52) | SLC22A1TP53GPR84FFAR1SLC22A2 | |
| Lactic Acid SCHEMBL9630457 | 0.96 | SLC22A1 (0.54) | SLC22A1TP53GPR84FFAR1SLC22A2 | |
| Lactic Acid SCHEMBL8907767 | 0.88 | TP53 (0.65) | TP53GPR84FFAR1ALDH1A1TSHR | |
| Tetrabuthylammonium SCHEMBL5874524 | 0.86 | SLC22A1 (0.55) | SLC22A1TP53GPR84FFAR1SLC22A2 | |
| Tetrabuthylammonium SCHEMBL107579 | 0.86 | SLC22A1 (0.55) | SLC22A1TP53GPR84FFAR1SLC22A2 | |
| Tetrapropylammonium SCHEMBL5574324 | 0.86 | TP53 (0.55) | SLC22A1TP53GPR84FFAR1TSHR | |
| Dodecane SCHEMBL6896604 | 0.85 | GPR84 (0.62) | TP53GPR84FFAR1ALDH1A1ALOX15 | |
| Hexadecane SCHEMBL29288627 | 0.85 | GPR84 (0.62) | TP53GPR84FFAR1ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 856 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250314970-A1 | OVERCOAT COMPOSITION AND PATTERNING METHODS | TOKYO ELECTRON LTD (JP) | 2025-10-09 | — | — | US | claimed |
| CN-118453443-A | Use of vitamin C lactate and analogues thereof in preparation of skin tissue products and related products | 长春圣博玛生物材料有限公司 | 2024-08-09 | — | — | CN | claimed |
| CN-115951561-B | Chemical amplification type positive I-line photoresist and preparation and use methods thereof | 徐州博康信息化学品有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-117234034-A | Photoresist and preparation and use methods thereof | 江西兆驰半导体有限公司 | 2023-12-15 | — | — | CN | claimed |
| CN-115951561-A | Chemically amplified positive I-line photoresist and preparation and use methods thereof | 徐州博康信息化学品有限公司 | 2023-04-11 | — | — | CN | claimed |
| US-6878504-B2 | Chemically-amplified resist compositions | EVERLIGHT USA, INC. (US) | 2005-04-12 | — | — | US | claimed |
| US-20040241569-A1 | Chemically-amplified resist compositions | EVERLIGHT USA, INC. | 2004-12-02 | — | — | US | claimed |
| US-6703178-B2 | COMPRISES A POLYMER CONTAINING A NOVEL LACTONE ALICYCLIC UNIT; WELL-BALANCED OUTCOME OF ETCHING RESISTANCE AND SUBSTRATE ADHESION | EVERLIGHT USA, INC. | 2004-03-09 | — | — | US | claimed |
| CN-1462909-A | Chemical amplification light resistance agent compsn. | AMERICAN EVERBRIGHT CORP (US) | 2003-12-24 | — | — | CN | claimed |
| US-20030232270-A1 | CHEMICAL AMPLIFIED PHOTORESIST COMPOSITIONS | EVERLIGHT USA, INC. (US) | 2003-12-18 | — | — | US | claimed |
| US-12607933-B2 | Polymer compositions having photoacid generators and photoresists | DUPONT ELECTRONICS, INC. (US) | 2026-04-21 | — | — | US | disclosed |
| US-12547072-B2 | Self-aligned build-up processing | GEMINATIO, INC. (US) | 2026-02-10 | — | — | US | disclosed |
| US-12503551-B2 | Fluorine-containing isocyanul compound | DAIKIN INDUSTRIES, LTD. (JP) | 2025-12-23 | — | — | US | disclosed |
| US-20250336673-A1 | METHODS FOR SUBSTRATE PATTERNING PROCESS | TOKYO ELECTRON LTD (JP) | 2025-10-30 | — | — | US | disclosed |
| US-20250314970-A1 | OVERCOAT COMPOSITION AND PATTERNING METHODS | TOKYO ELECTRON LTD (JP) | 2025-10-09 | — | — | US | disclosed |
| EP-0952489-A1 | Positive photosensitive resin composition | FUJI PHOTO FILM CO., LTD. (JP) | 1999-10-27 | — | — | EP | disclosed |
| EP-0930542-A1 | Polymers and photoresist compositions for short wavelength imaging | Shipley Company LLC (US) | 1999-07-21 | — | — | EP | disclosed |
| US-5879856-A | CONTROLLING PHOTOSPEED BY ADJUSTING AMOUNT OF LACTATE SALT PHOTOSPEED CONTROL AGENT IN PHOTORESIST COMPOSITION | SHIPLEY COMPANY, L.L.C. (US) | 1999-03-09 | — | — | US | disclosed |
| EP-0834770-A2 | Dyed photoresists and methods and articles of manufacture comprising same | Shipley Company LLC (US) | 1998-04-08 | — | — | EP | disclosed |
| EP-0783136-A2 | Chemically amplified positive photoresists | Shipley Company LLC (US) | 1997-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12547072-B2 | Self-aligned build-up processing | MYBBP1A, SMURF1, MYB | SLC22A1 4459/4885TP53 2830/4885GPR84 3481/4885 |
| US-12503551-B2 | Fluorine-containing isocyanul compound | AFF1, FLI1, RIF1 | SLC22A1 1509/4885TP53 1852/4885GPR84 4551/4885 |
| US-12607933-B2 | Polymer compositions having photoacid generators and photoresists | PFAS, AFF1, HBG1 | SLC22A1 2619/4885TP53 2060/4885GPR84 2156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.